[HTML][HTML] Relationship between Clavien–Dindo classification and long-term survival outcomes after curative resection for gastric cancer: A propensity score-matched …
Z Li, B Bai, G Ji, J Li, Q Zhao - International Journal of Surgery, 2018 - Elsevier
Background The impact of postoperative complications (POCs) on the long-term survival
outcomes after curative resection for gastric cancer has seldom been reported. The purpose …
outcomes after curative resection for gastric cancer has seldom been reported. The purpose …
[HTML][HTML] Adjuvant radiochemotherapy versus chemotherapy alone for gastric cancer: Implications for target definition
J Xu, J Zhu, Q Wei - Journal of Cancer, 2019 - ncbi.nlm.nih.gov
The INT0116 trial was a milestone study and laid the foundation for the adjuvant
radiotherapy (RT) associated to concurrent chemotherapy (CT) for the treatment of gastric …
radiotherapy (RT) associated to concurrent chemotherapy (CT) for the treatment of gastric …
Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy
Background The impact of adjuvant chemotherapy and chemo-radiation therapy in the
treatment of resectable gastric cancer remains varied. We sought to define the clinical …
treatment of resectable gastric cancer remains varied. We sought to define the clinical …
[HTML][HTML] Sophocarpine inhibits the growth of gastric cancer cells via autophagy and apoptosis
Y Huang, X Chen, G Guo, W Guo, Q Ma… - Frontiers in Bioscience …, 2019 - imrpress.com
Sophocarpine is one of the major ingredients of Sophorae flavescentis which could inhibits
many kinds of cancers. However, the effect of sophocarpine on gastric cancer (GC) and the …
many kinds of cancers. However, the effect of sophocarpine on gastric cancer (GC) and the …
Anti-metastatic efficacy of traditional Chinese medicine (TCM) ginsenoside conjugated to a VEFGR-3 antibody on human gastric cancer in an orthotopic mouse model
X Dai, D Liu, M Liu, X Zhang, W Wang, F Jin… - Anticancer …, 2017 - ar.iiarjournals.org
Background/Aim: The aim of the present study was to investigate the efficacy of a traditional
Chinese medicine (TCM), VEGFR-3 antibody-conjugated ginsenoside Rg 3 nanoemulsion …
Chinese medicine (TCM), VEGFR-3 antibody-conjugated ginsenoside Rg 3 nanoemulsion …
[HTML][HTML] Factores pronósticos de sobrevida alejada en cáncer gástrico. Introducción del nuevo índice N+/T
M Figueroa-Giralt - Revista chilena de cirugía, 2018 - SciELO Chile
Introducción: La identificación de factores pronósticos del cáncer gástrico, ha permitido
predecir la evolución de los pacientes y así tomar decisiones terapéuticas. En Chile existe …
predecir la evolución de los pacientes y así tomar decisiones terapéuticas. En Chile existe …
Introduction of the new lymphoparietal index for gastric cancer patients
M Figueroa-Giralt, A Csendes, K Carrillo… - … Brasileiros de Cirurgia …, 2019 - SciELO Brasil
Background: The identification of prognostic factors of gastric cancer (GC) has allowed to
predict the evolution of patients. Aim: Assess the reliability of the lymphoparietal index in the …
predict the evolution of patients. Aim: Assess the reliability of the lymphoparietal index in the …
[HTML][HTML] Impact of Adjuvant FOLFOX on Quality of Life and Peripheral Neuropathy Incidence in Patients With Gastric Cancer: A Prospective Cohort Study
Objectives Perioperative and adjuvant chemotherapy have demonstrated clinical benefits in
localized gastric cancer. Nevertheless, the reports on their effects on patient's health-related …
localized gastric cancer. Nevertheless, the reports on their effects on patient's health-related …
Distinguish the role of radiotherapy from chemoradiotherapy for gastric cancer with behavior of metastasis-indolent in lymph node
Y Zhi, Z Lin, J Ma, W Mou… - Technology in Cancer …, 2020 - journals.sagepub.com
Background: Although the landmark INT-0116 trial and National Comprehensive Cancer
Network (NCCN) guidelines recommended pT3-4Nx gastric cancer (GC) patients to receive …
Network (NCCN) guidelines recommended pT3-4Nx gastric cancer (GC) patients to receive …
[HTML][HTML] Adjuvant radiochemotherapy in locally advanced gastric cancer: from evidence to daily clinical practice in a single institution
M González-Domingo, C Ulloa, J Olivares… - …, 2020 - ncbi.nlm.nih.gov
Results With a median follow-up of 41 months, overall 3-and 5-year survival was 54.9% and
40.85%, respectively. On multivariate analysis, the factors associated with lower survival …
40.85%, respectively. On multivariate analysis, the factors associated with lower survival …